- Location
ventricular assist device
"-
Recent Disappointing Results for Ventricular Assist Device Companies
Nov 10, 2014Recent disappointing results for ventricular assist device companies are raising questions over adoption of the technology—which is meant to assist patients’ weakened hearts with pumping blood. HeartMate II, as shown on ...
-
Thoratec Has Replaced CEO with The Man Who Previously LED The Company for a Decade
Sep 30, 2014Thoratec Corp. has replaced CEO Gary Burbach with the man who previously led the company for a decade. New president and CEO Keith Grossman served in those roles at the Pleasanton, CA–based company from 1996 to 2006, when Burbach ...
-
HeartWare Tapped a Former Boston Scientific Executive
Aug 14, 2014Implantable heart pump maker HeartWare International recently announced that it has tapped a former Boston Scientific executive as its new chief medical officer, effective September 1. Katrin Leadley, MD, was most recently chief medical ...
-
A UCLA Team Has Developed an Easy-to-Use "Risk Calculator"
Jan 23, 2014A UCLA team has developed an easy-to-use "risk calculator" that helps predict heart failure patients' chances of survival for up to five years and assists doctors in determining whether more or less aggressive treatment is appropriate. ...
-
Japanese Approval for Jarvik 2000 Heart Is Announced by Jarvik Heart
Dec 9, 2013Jarvik Heart, a manufacturer of cardiac assist devices, has announced the Shonin approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the Jarvik 2000 heart, a small left ventricular assist device implanted inside ...
-
LLC Avalon Will Showcase Capabilities to Offer Feature-Rich Single Piece Medical Devices
Nov 28, 2013Avalon Laboratories, LLC Avalon will showcase its capabilities to offer feature-rich single piece medical devices not currently available with extrusion technology in booth #204 at BIOMEDevice San Jose. Avalon will showcase its ...
Tags: Avalon, present, polymer, solution casting, technology, feature-rich
-
Thoratec Has Gained an Investigational Device Exemption
Jan 9, 2013Thoratec has gained an investigational device exemption(IDE)from the US Food and Drug Administration(FDA)for the initiation of a feasibility clinical study of its continuous-flow left ventricular assist device(LVAD),for the treatment of ...
-
Thoratec's Heartmate II for Use as a Bridge-to-Transplantation Therapy Has Been Approved
Dec 13, 2012The Japan's Ministry of Health, Labour and Welfare has approved Thoratec's HeartMate II for use as a Bridge-to-Transplantation therapy for patients with advanced heart failure. The approval was based on a confirmatory clinical study, ...
Tags: Japan, health, therapy, heart failure
-
Cleveland Heart Obtains $30m Grant to Develop Its Smartheart
Aug 17, 2012Cleveland Heart, a joint venture between Cleveland Clinic and TransWorld Medical Devices, has obtained $30m grant from Power Heart Consortium to develop its SmartHeart, continue international clinical trials, expand laboratory research and ...
Tags: clinic development, LVAD, investment